It was reported on November 27, that Michael J Farrell, Chief Executive Officer at ResMed RMD executed a significant insider ...

Shares of ResMed Inc. RMD slipped 0.26% to $249.33 Wednesday, on what proved to be an all-around rough trading session for ...

Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD) has released an update.Don't Miss our Black Friday ...

What Happened: In a Form 4 filing with the U.S. Securities and Exchange Commission on Wednesday, Farrell, Chief Executive Officer at ResMed, acquired stock options for 33,036 shares of RMD. These ...

ResMed Inc. is downgraded from buy to watchful hold due to valuation concerns, despite strong financial performance and ...

Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD) has released an update.Don't Miss our Black Friday ...

With a market cap of $35.8 billion, ResMed Inc. (RMD) is a global leader in the design, manufacturing, and distribution of ...

Analyzing ResMed Inc.'s Q1 2025 results, stock performance, and sentiment to determine if further upside or profit taking is ...

Shares of ResMed Inc. RMD inched 0.17% higher to $249.99 Tuesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 0.57% to 6,021.63 ...

ResMed Inc. has a 1 year low of $151.95 and a 1 year high of $260.49. The firm has a market capitalization of $36.65 billion, a PE ratio of 33.07, a P/E/G ratio of 1.77 and a beta of 0.69.

ResMed is taking a “smart devices” and Big Data approach to further entrench itself as one of the two leading players in the global obstructive sleep apnea, or OSA, market. With cloud ...